Predictors of cost-effectiveness of selected COPD treatments in primary care: UNLOCK study protocol

npj Primary Care Respiratory Medicine

Volumn 25, Issue , 2015, Pages

  Van Boven, Job F M ^a   Román Rodríguez, Miguel ^b   Kocks, Janwillem W H ^c   Soriano, Joan B ^d   Postma, Maarten J ^a,c   Van Der Molen, Thys ^c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Institut D'Investigació Sanitaria de Palma IdISPa   (Spain)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MALE; MEDICATION COMPLIANCE; PRIMARY MEDICAL CARE; SMOKING; SPAIN; COHORT ANALYSIS; COST BENEFIT ANALYSIS; DRUG COST; ECONOMICS; FACTUAL DATABASE; HEALTH CARE COST; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDY;

COHORT STUDIES; COST-BENEFIT ANALYSIS; DATABASES, FACTUAL; DRUG COSTS; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SPAIN;

EID: 84938845185     PISSN: None     EISSN: 20551010     Source Type: Journal    
DOI: 10.1038/npjpcrm.2015.51     Document Type: Article

References (20)

1. World Health Organization. Chronic obstructive pulmonary disease. Available at http://www.who.int/respiratory/copd/en/. Accessed 22 February 2015.
2. van Boven JF, Vegter S, van der Molen T, Postma MJ. COPD in the working age population: the economic impact on both patients and government. COPD 2013; 10: 629-639.
3. Lababidi H, Abu-Shaheen AK, Bou Mehdi IA, Al-Tannir MA. Asthma care practicing among general practitioners in Lebanon: a cross-sectional study. J Asthma 2014; 51: 51-57.
4. de Miguel-Diez J, Carrasco-Garrido P, Rejas-Gutierrez J, Martin-Centeno A, Gobartt-Vazquez E, Hernandez-Barrera V et al. Inappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health status. Lung 2011; 189: 199-206.
5. Pozo-Rodriguez F, Lopez-Campos JL, Alvarez-Martinez CJ, Castro-Acosta A, Aguero R, Hueto J et al. Clinical audit of COPD patients requiring hospital admissions in Spain: AUDIPOC study. PLoS One 2012; 7: e42156.
6. Lopez-Campos JL, Hartl S, Pozo-Rodriguez F, Roberts CM. European COPD Audit team. Variability of hospital resources for acute care of COPD patients: the European COPD Audit. Eur Respir J 2014; 43: 754-762.
7. Izquierdo-Alonso JL, de Miguel-Diez J. Economic impact of pulmonary drugs on direct costs of stable chronic obstructive pulmonary disease. COPD 2004; 1: 215-223.
8. Soriano JB, Yanez A, Renom F, de la Pena M, Gomez A, Duro R et al. Set-up and pilot of a population cohort for the study of the natural history of COPD and OSA: the PULSAIB study. Prim Care Respir J 2010; 19: 140-147.
9. de Miguel Diez J, Carrasco Garrido P, Garcia Carballo M, Gil de Miguel A, Rejas Gutierrez J, Bellon Cano JM et al. Determinants and predictors of the cost of COPD in primary care: a Spanish perspective. Int J Chron Obstruct Pulmon Dis 2008; 3: 701-712.
10. Mapel DW, McMillan GP, Frost FJ, Hurley JS, Picchi MA, Lydick E et al. Predicting the costs of managing patients with chronic obstructive pulmonary disease. Respir Med 2005; 99: 1325-1333.
11. Garcia-Polo C, Alcazar-Navarrete B, Ruiz-Iturriaga LA, Herrejon A, Ros-Lucas JA, Garcia-Sidro P et al. Factors associated with high healthcare resource utilisation among COPD patients. Respir Med 2012; 106: 1734-1742.
12. Verdaguer Munujos A, Peiro S, Librero J. Variations in the use of hospital resources in treating patients with chronic obstructive pulmonary disease. Arch Bronconeumol 2003; 39: 442-448.
13. Sharif R, Cuevas CR, Wang Y, Arora M, Sharma G. Guideline adherence in management of stable chronic obstructive pulmonary disease. Respir Med 2013; 107: 1046-1052.
14. Perez X, Wisnivesky JP, Lurslurchachai L, Kleinman LC, Kronish IM. Barriers to adherence to COPD guidelines among primary care providers. Respir Med 2012; 106: 374-381.
15. Miravitlles M, Sicras A, Crespo C, Cuesta M, Brosa M, Galera J et al. Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting. Ther Adv Respir Dis 2013; 7: 139-150.
16. Chavannes N, Stallberg B, Lisspers K, Roman M, Moran A, Langhammer A et al. UNLOCK: Uncovering and Noting Long-term Outcomes in COPD to enhance knowledge. Prim Care Respir J 2010; 19: 408.
17. Official Bulletin of the Balearic Islands. Available at http://boib.caib.es/pdf/2012040/mp63.pdf. Accessed 20 February 2015.
18. Herland K, Akselsen JP, Skjonsberg OH, Bjermer L. How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease Respir Med 2005; 99: 11-19.
19. Kruis AL, Stallberg B, Jones RC, Tsiligianni IG, Lisspers K, van der Molen T et al. Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study. PLoS One 2014; 9: e90145.
20. Conway PH, Clancy C. Comparative-effectiveness research-implications of the Federal Coordinating Council's report. N Engl J Med 2009; 361: 328-330.